Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Current Leases (2021 - 2026)

SkinHealth Systems has reported Current Leases over the past 5 years, most recently at $5.1 million for Q4 2025.

  • Quarterly Current Leases changed 0.37% to $5.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Dec 2025, changed 0.37% year-over-year, with the annual reading at $5.1 million for FY2025, 0.37% changed from the prior year.
  • Current Leases was $5.1 million for Q4 2025 at SkinHealth Systems, up from $5.0 million in the prior quarter.
  • Over five years, Current Leases peaked at $5.2 million in Q2 2025 and troughed at $3.7 million in Q4 2021.
  • The 5-year median for Current Leases is $4.9 million (2023), against an average of $4.7 million.
  • Year-over-year, Current Leases surged 33.57% in 2022 and then dropped 12.71% in 2024.
  • A 5-year view of Current Leases shows it stood at $3.7 million in 2021, then skyrocketed by 33.57% to $5.0 million in 2022, then fell by 7.26% to $4.6 million in 2023, then grew by 11.94% to $5.1 million in 2024, then decreased by 0.37% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Current Leases are $5.1 million (Q4 2025), $5.0 million (Q3 2025), and $5.2 million (Q2 2025).